Levothyroxine Sodium
Product Images NDC 70934-590

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70934-590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)
Chemical structure diagram of Levothyroxine Sodium, showing the molecular arrangement including iodine atoms and carboxyl functional groups with sodium and water components indicated.*
FDA Label Image

Label (70934 590 30 Master Bottle Label Approval Rev A 02 20)

Label (70934 590 30 Master Bottle Label Approval Rev A 02 20)
Levothyroxine Sodium Tablets USP 137 mcg (0.137 mg), 30 tablets per bottle, labeler Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label includes dosage and storage instructions, NDC 70934-590-30, and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.